Literature DB >> 18182299

Emerging roles of Abl family tyrosine kinases in microbial pathogenesis.

Steffen Backert1, Stephan M Feller, Silja Wessler.   

Abstract

Abl family kinases are central regulators of multiple cellular processes controlling actin dynamics, proliferation and differentiation. Recent studies indicate that different pathogens highjack Abl kinase signalling to reorganize the host actin cytoskeleton and promote the tyrosine phosphorylation of four known bacterial and viral effector proteins. Abl signalling is implicated in such diverse processes as microbial invasion, viral release from host cells, actin-based motility, actin-rich pedestal formation and cell scattering. Thus, Abl kinases are emerging as crucial regulators of multiple pathological signalling cascades during infection. Therapeutic intervention against Abl kinase activity might be an effective and novel strategy to combat serious microbial diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182299     DOI: 10.1016/j.tibs.2007.10.006

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  33 in total

1.  The cytoplasmic tyrosine kinase Arg regulates gastrulation via control of actin organization.

Authors:  Gustavo Bonacci; Jason Fletcher; Madhav Devani; Harsh Dwivedi; Ray Keller; Chenbei Chang
Journal:  Dev Biol       Date:  2012-01-18       Impact factor: 3.582

2.  The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility.

Authors:  Ina Weisswange; Timothy P Newsome; Sibylle Schleich; Michael Way
Journal:  Nature       Date:  2009-03-05       Impact factor: 49.962

3.  Evidence for moonlighting functions of the θ subunit of Escherichia coli DNA polymerase III.

Authors:  M Dietrich; L Pedró; J García; M Pons; M Hüttener; S Paytubi; C Madrid; A Juárez
Journal:  J Bacteriol       Date:  2013-12-27       Impact factor: 3.490

4.  A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis.

Authors:  Manikuntala Kundu; Sushil Kumar Pathak; Kuldeep Kumawat; Sanchita Basu; Gargi Chatterjee; Shresh Pathak; Takuya Noguchi; Kohsuke Takeda; Hidenori Ichijo; Christine B F Thien; Wallace Y Langdon; Joyoti Basu
Journal:  Nat Immunol       Date:  2009-07-13       Impact factor: 25.606

Review 5.  Abl tyrosine kinases in T-cell signaling.

Authors:  Jing Jin Gu; Jae Ryun Ryu; Ann Marie Pendergast
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

6.  c-Abl and Src-family kinases cross-talk in regulation of myeloid cell migration.

Authors:  Anna Baruzzi; Ilaria Iacobucci; Simona Soverini; Clifford A Lowell; Giovanni Martinelli; Giorgio Berton
Journal:  FEBS Lett       Date:  2010-01-04       Impact factor: 4.124

7.  Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection.

Authors:  Hagit Sason; Michal Milgrom; Aryeh M Weiss; Naomi Melamed-Book; Tamas Balla; Sergio Grinstein; Steffen Backert; Ilan Rosenshine; Benjamin Aroeti
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

8.  Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step.

Authors:  Brooke Harmon; Nancy Campbell; Lee Ratner
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

9.  An RNA replication-center assay for high content image-based quantifications of human rhinovirus and coxsackievirus infections.

Authors:  Andreas Jurgeit; Stefan Moese; Pascal Roulin; Alexander Dorsch; Mark Lötzerich; Wai-Ming Lee; Urs F Greber
Journal:  Virol J       Date:  2010-10-11       Impact factor: 4.099

10.  F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infection.

Authors:  João V Cordeiro; Susana Guerra; Yoshiki Arakawa; Mark P Dodding; Mariano Esteban; Michael Way
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.